J&J quarterly sales beat expectations; 2019 forecast below expectation

J&J quarterly sales beat expectations; 2019 forecast below expectation

Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts’ estimates and said it expected further pressure on US prescription drug prices. J&J said it expects full-year sales of $80.4 billion to $81.2 billion. Sales in the fourth quarter rose about 1 per cent to $20.39 billion.

KCooper
KCooper
Top in Business
Get the App